HEALTHCARE & MEDICARE
-
GoodRx launches employer program to help subsidize high-cost brand-name drugs
GoodRx has launched the GoodRx Employer Direct program, which allows employers to subsidize the manufacturer-sponsored price of high-cost brand-name drugs…
Read More » -
Atrium Therapeutics spends $270 million to launch RNA therapy to treat rare heart disease
Atrium was spun off from Avidity Biosciences, which Novartis acquired in a $12 billion deal. Atrium's pipeline is led by…
Read More » -
Healthcare Initiatives: Monthly Summary of Hirings, Separations and Layoffs
February saw a flurry of executive hirings, promotions and layoffs across the healthcare industry. For example, CDC, Nabla and symplr…
Read More » -
Generate Biomedicines IPO raises $400 million for pivotal test of severe asthma drug
Generate Biomedicines, the flagship company created by Pioneer, aims to inject less frequently than best-selling asthma drugs from partners Amgen…
Read More » -
Where patient experience is heading – and 3 ways healthcare providers can prepare for the moment
Healthcare providers need to consider not only the experiences patients need and want now, but also the experiences they will…
Read More » -
How Elevance Health uses artificial intelligence, and how it doesn’t
Ratnakar Lavu, chief digital officer at Elevance Health, said the company is using artificial intelligence to streamline approvals, claims processing…
Read More » -
FDA coupon prompts fast approval of Boehringer Ingelheim drug for first-line lung cancer treatment
The label expansion for Boehringer Ingelheim's Hernexeos comes under an FDA pilot program that expedites regulatory review of products of…
Read More » -
Where to buy laboratory freeze dryers for sample preservation
[Sponsored] Biological samples are the foundation of modern scientific research and medicine, providing breakthroughs in diagnosis, treatment development, and understanding…
Read More » -
Compliance: Why your suppliers’ suppliers are a growth risk
The core challenge for leadership is no longer just managing direct suppliers; it is the cascading risk of “nth party”…
Read More » -
Rare Disease Day 2026: From recognition to patients getting exceptional care during a tumultuous year
It’s not just about awareness, it’s a call to action for patients, families, employers, payers and policymakers to modernize the…
Read More »